Galderma Group AG (GALD) Stock Forecast & Price Target

Compare

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GALD Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Galderma

Group AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GALD Stock 12 Month Forecast

Average Price Target

CHF161.56

▼(-2.38% Downside)

Based on 10 Wall Street analysts offering 12 month price targets for Galderma Group AG in the last 3 months. The average price target is CHF161.56 with a high forecast of CHF190.00 and a low forecast of CHF135.00. The average price target represents a -2.38% change from the last price of CHF165.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"94":"CHF94","191":"CHF191","118.25":"CHF118.3","142.5":"CHF142.5","166.75":"CHF166.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":190,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF190.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":161.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF161.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":135,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF135.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[94,118.25,142.5,166.75,191],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.1,160.55384615384614,163.0076923076923,165.46153846153845,167.91538461538462,170.36923076923077,172.8230769230769,175.27692307692308,177.73076923076923,180.18461538461537,182.63846153846154,185.09230769230768,187.54615384615386,{"y":190,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.1,158.36615384615385,158.63230769230768,158.89846153846153,159.1646153846154,159.43076923076922,159.69692307692307,159.96307692307693,160.22923076923078,160.4953846153846,160.76153846153846,161.02769230769232,161.29384615384615,{"y":161.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.1,156.3230769230769,154.54615384615383,152.76923076923077,150.9923076923077,149.2153846153846,147.43846153846152,145.66153846153847,143.8846153846154,142.1076923076923,140.33076923076922,138.55384615384617,136.77692307692308,{"y":135,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":100.47,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF190.00

Average Price TargetCHF161.56

Lowest Price TargetCHF135.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Benjamin Jackson CFA

Jefferies

CHF160

Buy

-3.32%

Downside

Reiterated

12/08/25

Strategic Partnership and Stake Increase Drive Positive Outlook for Galderma: Buy Recommendation

Yihan Li

Barclays

CHF155

Buy

-6.34%

Downside

Reiterated

12/08/25

Barclays Sticks to Their Buy Rating for Galderma Group AG (GALD)

Matthew Weston

UBS

CHF190

Buy

14.80%

Upside

Upgraded

11/25/25

Positive Report for Galderma Group AG (GALD) from UBS

Natalia Webster

RBC Capital

CHF140

Hold

-15.41%

Downside

Reiterated

10/29/25

RBC Capital Remains a Hold on Galderma Group AG (GALD)

Justine Telliez

Kepler Capital

CHF165→CHF167

Buy

0.91%

Upside

Reiterated

10/28/25

Kepler Capital Sticks to Its Buy Rating for Galderma Group AG (GALD)

Cedric Besnard

Citi

CHF140→CHF165

Buy

-0.30%

Downside

Reiterated

10/24/25

Citi Remains a Buy on Galderma Group AG (GALD)

Thibault Boutherin

Morgan Stanley

CHF135

Hold

-18.43%

Downside

Reiterated

10/23/25

Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced OutlookWe expect the stock to outperform with the 3 divisions strong, a Q3 beat on the most important drivers (aesthetics & FY25 guide raise FY25 guidance upgrade: sales growth upgraded from 12-14% to 17-17.7% CER and core EBITDA margin CER raised from ~23% to 23-1%-23.6% The guidance upgrade implies 2% sales upgrade / 4% core EBITDA upgrade to consensus FY25 numbers Q3 sales are very strong in the context of market softness for consumer, with Galderma outgrowing the market and gaining share through new product launches 06:24 AM GMT Downloaded by Not for redistribution without written consent of FY25 sales upgrades and 4% FY25 core EBITDA upgrade; consensus FY estimates.

Bethan Davies

Berenberg Bank

CHF165→CHF182

Buy

9.97%

Upside

Reiterated

10/16/25

Berenberg Bank Remains a Buy on Galderma Group AG (GALD)

Unknown Analyst

Bank Vontobel

Not Ranked

Bank Vontobel

―

Buy

―

Upgraded

10/06/25

Galderma Group AG (GALD) was upgraded to a Buy Rating at Bank Vontobel

Chris Shibutani

Goldman Sachs

CHF140→CHF160

Buy

-3.32%

Downside

Reiterated

09/16/25

Galderma Group AG (GALD) Gets a Buy from Goldman Sachs

James Gordon

J.P. Morgan

CHF120→CHF160

Buy

-3.32%

Downside

Reiterated

07/25/25

J.P. Morgan Reaffirms Their Buy Rating on Galderma Group AG (GALD)JPMorgan analyst James Gordon raised the price target on Galderma Group AG (GALD:SW) to CHF160.00 (from CHF120.00) while maintaining a Overweight rating.

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

―

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Unknown Analyst

Peel Hunt

Not Ranked

Peel Hunt

―

Buy

―

Reiterated

06/30/25

Peter Verdult

Exane BNP Paribas

CHF100

Buy

-39.58%

Downside

Initiated

04/16/25

BNP Paribas Exane Starts Galderma Group AG (GALD:SW) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Galderma Group AG (GALD:SW) with a Outperform rating and a price target of CHF100.00.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Benjamin Jackson CFA

Jefferies

CHF160

Buy

-3.32%

Downside

Reiterated

12/08/25

Strategic Partnership and Stake Increase Drive Positive Outlook for Galderma: Buy Recommendation

Yihan Li

Barclays

CHF155

Buy

-6.34%

Downside

Reiterated

12/08/25

Barclays Sticks to Their Buy Rating for Galderma Group AG (GALD)

Matthew Weston

UBS

CHF190

Buy

14.80%

Upside

Upgraded

11/25/25

Positive Report for Galderma Group AG (GALD) from UBS

Natalia Webster

RBC Capital

CHF140

Hold

-15.41%

Downside

Reiterated

10/29/25

RBC Capital Remains a Hold on Galderma Group AG (GALD)

Justine Telliez

Kepler Capital

CHF165→CHF167

Buy

0.91%

Upside

Reiterated

10/28/25

Kepler Capital Sticks to Its Buy Rating for Galderma Group AG (GALD)

Cedric Besnard

Citi

CHF140→CHF165

Buy

-0.30%

Downside

Reiterated

10/24/25

Citi Remains a Buy on Galderma Group AG (GALD)

Thibault Boutherin

Morgan Stanley

CHF135

Hold

-18.43%

Downside

Reiterated

10/23/25

Bethan Davies

Berenberg Bank

CHF165→CHF182

Buy

9.97%

Upside

Reiterated

10/16/25

Berenberg Bank Remains a Buy on Galderma Group AG (GALD)

Unknown Analyst

Bank Vontobel

Not Ranked

Bank Vontobel

―

Buy

―

Upgraded

10/06/25

Galderma Group AG (GALD) was upgraded to a Buy Rating at Bank Vontobel

Chris Shibutani

Goldman Sachs

CHF140→CHF160

Buy

-3.32%

Downside

Reiterated

09/16/25

Galderma Group AG (GALD) Gets a Buy from Goldman Sachs

James Gordon

J.P. Morgan

CHF120→CHF160

Buy

-3.32%

Downside

Reiterated

07/25/25

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

―

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Unknown Analyst

Peel Hunt

Not Ranked

Peel Hunt

―

Buy

―

Reiterated

06/30/25

Peter Verdult

Exane BNP Paribas

CHF100

Buy

-39.58%

Downside

Initiated

04/16/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Galderma Group AG

1 Month

xxx

Success Rate

5/6 ratings generated profit

Average Return

+5.08%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 83.33% of your transactions generating a profit, with an average return of +5.08% per trade.

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+20.50%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +20.50% per trade.

1 Year

Bethan DaviesBerenberg Bank

Success Rate

5/5 ratings generated profit

Average Return

+48.68%

reiterated a buy rating 2 months ago

Copying Bethan Davies's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +48.68% per trade.

2 Years

xxx

Success Rate

5/5 ratings generated profit

Average Return

+48.68%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +48.68% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GALD Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GALD has received 24 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. GALD average Analyst price target in the past 3 months is 161.56.

Each month's total comprises the sum of three months' worth of ratings.

GALD Financial Forecast

GALD Earnings Forecast

Next quarter’s earnings estimate for GALD is CHF1.18 with a range of CHF0.88 to CHF1.39. The previous quarter’s EPS was CHF1.12. GALD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GALD has Performed in-line its overall industry.

GALD Sales Forecast

Next quarter’s sales forecast for GALD is CHF1.11B with a range of CHF1.10B to CHF1.13B. The previous quarter’s sales results were CHF2.11B. GALD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GALD has Performed in-line its overall industry.

GALD Stock Forecast FAQ

What is CH:GALD’s average 12-month price target, according to analysts?

Based on analyst ratings, Galderma Group AG’s 12-month average price target is 161.56.

What is CH:GALD’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:GALD, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Galderma Group AG a Buy, Sell or Hold?

Galderma Group AG has a consensus rating of Strong Buy, which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Galderma Group AG’s share price target?

The average share price target for Galderma Group AG is 161.56. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF190.00 ,and the lowest forecast is CHF135.00. The average share price target represents -2.38% Decrease from the current price of CHF165.5.

What do analysts say about Galderma Group AG?

Galderma Group AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Galderma Group AG?

To buy shares of CH:GALD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Galderma Group AG (GALD) Stock Forecast & Price Target

GALD Analyst Ratings

GALD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Galderma Group AG

GALD Analyst Recommendation Trends

GALD Financial Forecast

GALD Earnings Forecast

GALD Sales Forecast

GALD Stock Forecast FAQ

Detailed List of Analyst Forecasts